Turning Probabilities Into Realities

  1. Firm News
  2.  → Did Zantac use result in a cancer diagnosis?

Did Zantac use result in a cancer diagnosis?

| Jan 19, 2021 | Firm News, Multidistrict Litigation |

If you or a loved one has been diagnosed with cancer, the diagnosis may have root causes that you have never even considered. This is the case for many who have been diagnosed with cancer after using Zantac or its generic equivalent, ranitidine. While the drug was prescribed to treat acid reflux, stomach ulcers and other gastrointestinal disorders, its use has been linked to cancers of the stomach, esophagus, spleen and other internal organs.

What happened?

In April of 2020, the FDA requested the removal of all products containing ranitidine from the market after a study turned up evidence that those products contained unsafe amounts of a cancer-causing substance called NDMA. While minute amounts of NDMA exist in food and water, prolonged ingestion can cause an unsafe risk of cancer. In the case of Zantac and other products containing ranitidine, the risk increases the longer the product is stored and when the product is exposed to high temperatures during storage or distribution.

What can you do?

If you or a family member had been diagnosed with cancer, legal concerns may be far from your mind. Pursuing a legal claim can, however, provide you with monetary compensation to help with your medical bills and other hardships. It can also impact safety protocols in the drug industry, holding negligent manufacturers accountable and making the market safer for others.

If you believe use of Zantac or other product containing ranitidine may have contributed to your cancer diagnosis, you have important legal rights you should know about. To explore your options, talk to an attorney who has experience handling multidistrict litigation of this kind.